证券日报网讯 11月17日晚间，思创医惠（300078）发布公告称，同意增选何毅琦先生为公司第六届董 事会独立董事。 ...

Core Viewpoint - The company, Sichuang Medical (SZ 300078), announced a board meeting to discuss management buyout matters, indicating potential strategic shifts in ownership and governance [1] Financial Performance - For the first half of 2025, the revenue composition of Sichuang Medical was as follows: property sales accounted for 53.84%, business intelligence for 39.28%, and smart healthcare for 6.87% [1] - The current market capitalization of Sichuang Medical is 4.2 billion yuan [1]

Core Viewpoint - The company is undergoing a significant change in its shareholding structure, with the largest shareholder, Mr. Lu Nan, transferring a substantial portion of his shares to Cangnan Xincheng, which will lead to a shift in control of the company to Mr. Wei Naixu. Group 1: Share Transfer Details - Mr. Lu Nan, the largest shareholder, will transfer 62,739,500 shares, representing 5.61% of the total share capital, to Cangnan Xincheng [1] - After the transfer, Mr. Lu's direct shareholding will decrease from 62,739,500 shares to 0 shares, while his indirect holding through Hangzhou Botai Investment Management Co., Ltd. will be 6,006,776 shares, or 0.54% of the total share capital [1] - The total share capital of the company is 1,117,872,230 shares [1] Group 2: Voting Rights Delegation - The shareholder, Sijia Wulian, has signed a voting rights delegation agreement with Cangnan Xincheng and its actual controller, Mr. Wei Naixu, to delegate voting rights for 63,890,185 shares, which is 5.72% of the total share capital [2] - The delegation of voting rights will be effective for 36 months from the date of approval by the company's shareholders' meeting [2] - Sijia Wulian and Cangnan Xincheng do not have any other related party relationships [2] Group 3: Control and Shareholding Structure Post-Transfer - Cangnan Xincheng will directly hold 62,739,500 shares after the transfer, while Mr. Wei Naixu will indirectly hold a total of 83,471,940 shares through Cangnan Xincheng and Cangnan Xinchuang, representing 7.47% of the total share capital [3] - The total number of shares with voting rights will amount to 147,362,125 shares, or 13.18% of the total share capital [3] - Following these changes, Cangnan Xincheng will become the controlling shareholder, and the company's control will shift from having no actual controller to being under the control of Mr. Wei Naixu [3]

Core Viewpoint - The share transfer agreement between Mr. Lu Nan, the largest shareholder of Sichuan Medical Technology Co., Ltd. (300078.SZ), and Cangnan Construction Investment Co., Ltd. has been terminated due to the lack of approval from relevant state-owned asset supervision authorities [1][2] Group 1 - Mr. Lu Nan intends to transfer 62,739,500 shares, representing 5.61% of the company's total share capital, to Cangnan Construction Investment [1] - After the transfer, Cangnan Construction Investment will hold 62,739,500 shares, and together with Cangnan Sijia Internet of Things Intelligent Partnership, they will control 11.33% of the company's total shares [1] - The control of the company will shift from Mr. Lu Nan and his action-in-concert party to Cangnan Construction Investment and its action-in-concert party, indicating a change in the company's actual controller to the Cangnan County Finance Bureau [1] Group 2 - The Zhejiang Provincial State-owned Assets Supervision and Administration Commission returned the application materials for the acquisition of control over Sichuan Medical Technology, stating that the proposal did not meet regulatory requirements [2] - Following the return of the application, Cangnan Construction Investment issued a notice to terminate the share transfer agreement, as the lack of approval triggered a clause allowing for termination without liability [2] - Both parties agreed to terminate the share transfer to protect their interests and avoid unnecessary losses [2]

Core Viewpoint - The announcement reveals a significant change in the ownership structure of Sichuang Medical, with the largest shareholder, Lu Nan, transferring 5.61% of shares to Cangnan Xinshi Enterprise Management Partnership, controlled by Wei Naixu, making him the actual controller of the company [1][3]. Group 1: Share Transfer and Control - Lu Nan, the largest shareholder of Sichuang Medical, plans to transfer 5.61% of his shares to Cangnan Xinshi, which will become the controlling shareholder after the transfer [1]. - Wei Naixu, as the executive partner of Cangnan Xinshi, will effectively control the company through this transfer [1]. - Cangnan Xinshi was established with a total investment of 300 million yuan, with Wei Naixu holding a 1% stake [1][3]. Group 2: Background of Cangnan Xinshi - Cangnan Xinshi's structure includes Cangnan Industrial Construction Investment Co., Ltd., which holds a 33.33% stake and is controlled by the Cangnan County Finance Bureau, indicating a state-owned background [3]. - The acquisition of control over Sichuang Medical is now being conducted through an investment fund rather than direct shareholding, which is expected to create a win-win situation for all parties involved [3]. Group 3: Strategic Adjustments - Sichuang Medical has approved a restructuring plan aimed at streamlining operations and enhancing strategic management, focusing on the Internet of Things sector [3]. - The restructuring is intended to clarify responsibilities and strengthen strategic control, thereby supporting the company's growth and increasing shareholder value [3]. Group 4: Future Outlook - With the ongoing support from state-owned shareholders, Wei Naixu aims to enhance the company's competitiveness by optimizing the industrial chain, incubating new businesses, and exploring new markets [4]. - The goal is to achieve sustainable and high-quality development, ultimately creating long-term value for all shareholders [4].

同日，公司股东苍南县思加物联智能合伙企业（有限合伙）（以下简称"思加物联"）与苍南芯盛及其实 际控制人魏乃绪共同签署了《表决权委托协议》，约定在协议有效期内，思加物联不可撤销地将持有的 公司6389.02万股（占总股本5.72%）股份以及上述股份因配股、送股、转增股本等而增加的股份对应的 表决权、召集权、提名和提案权、参会权等相关权利委托给苍南芯盛行使。 思创医惠表示，苍南芯盛与苍南芯创企业管理合伙企业（有限合伙）（以下简称"苍南芯创"）同为魏乃 绪控制的企业，苍南芯创持有公司股份2073.24万股，对应占公司总股本的比例为1.85%。本次股份转让 手续办理完成及表决权委托事项生效后，魏乃绪通过苍南芯盛和苍南芯创间接持有公司股份合计 8347.19万股，对应占公司总股本的7.47%；拥有表决权的股份数合计为1.47亿股，对应占公司总股本的 13.18%；苍南芯盛将成为公司的控股股东，公司的控制权将从无实际控制人变更为魏乃绪。 北京商报讯（记者 丁宁）11月17日晚间，思创医惠（300078）发布公告称，公司第一大股东路楠与公 司董事兼总经理魏乃绪控制的企业苍南芯盛企业管理合伙企业（有限合伙）（以下简称"苍南芯 ...

据了解，公司第一大股东路楠与苍南县工业建设投资有限公司(以下简称"苍南建投")于4月26日签署了 《股份转让协议》，约定路楠拟通过协议转让的方式将其所直接持有的公司共计6273.95万股的股份(占 公司总股本的5.61%)转让给苍南建投。本次股份转让过户完成后，公司的控制权将从无实际控制人变更 为苍南县财政局。 思创医惠表示，11月14日，针对上述股份转让事项，浙江省国资委办公室出具了《关于退回收购思创医 惠科技股份有限公司控制权项目材料的函》显示，经相关国有资产监督管理机构研究决定，苍南建投关 于收购思创医惠控制权项目的申报方案不符合国资监管关于上市公司控制权收购的有关要求，退回其申 报材料。同日，根据协议，苍南建投向出让方路楠出具了《解除协议通知书》。为最大限度维护交易双 方及公司利益，避免不必要的损失，经双方友好协商，一致同意终止本次股份转让事项，本次股份转让 事项终止。 北京商报讯(记者丁宁)11月17日晚间，思创医惠（300078）发布公告称，股东解除《股份转让协议》， 实际控制人、控股股东终止变更。 ...

每经AI快讯，11月17日，思创医惠（300078）(300078.SZ)公告称，公司第一大股东路楠与苍南芯盛企 业管理合伙企业(有限合伙)签署《股份转让协议》，路楠拟将其直接持有的公司6273.95万股股份(占公 司总股本的5.61%)转让给苍南芯盛。同时，公司股东思加物联与苍南芯盛及其实际控制人魏乃绪签署 《表决权委托协议》，思加物联将持有的公司6389.02万股股份(占总股本的5.72%)对应的表决权委托给 苍南芯盛行使。本次权益变动完成后，魏乃绪将通过苍南芯盛和苍南芯创间接持有公司7.47%的股份， 拥有13.18%的表决权。待前述事项全部完成后，苍南芯盛将成为公司的控股股东，公司的控制权将从 无实际控制人变更为魏乃绪。此次权益变动尚需通过深圳证券交易所合规性审核及中国证券登记结算有 限责任公司深圳分公司办理协议转让相关过户手续。 ...

证券代码：300078 证券简称：思创医惠 公告编号：2025-110 2025 年 11 月 14 日，针对上述股份转让事项，浙江省国资委办公室出具了 《关于退回收购思创医惠科技股份有限公司控制权项目材料的函》："经相关国 有资产监督管理机构研究决定，苍南建投关于收购思创医惠控制权项目的申报方 案不符合国资监管关于上市公司控制权收购的有关要求，退回其申报材料。"同 日，根据协议，苍南建投向出让方路楠先生出具了《解除协议通知书》，因本次 股份转让事项未能获得相关国有资产监督管理机构审批通过，触发《股份转让协 议》第 7.7 条："双方特别约定，乙方作为国有股东受让上市公司股份，依法应 报经相关国有资产监督管理机构审核批准，如监管机构的审核结论为不批准本次 受让的，乙方有权通知解除本协议，且无需为此承担违约责任。股份转让款返还 事宜按本协议 7.8 条约定执行。" 思创医惠科技股份有限公司 关于股东解除《股份转让协议》暨实际控制人、控股股东终止变更的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、前期基本情况概述 思创医惠科技股份有限公司（以下简称"公 ...

2、同日，公司股东苍南县思加物联智能合伙企业（有限合伙）（以下简称 "思加物联"）与苍南芯盛及其实际控制人魏乃绪先生共同签署了《表决权委托 协议》，约定在协议有效期内，思加物联不可撤销地将持有的上市公司 63,890,185 股（占总股本 5.72%）股份以及上述股份因配股、送股、转增股本等 而增加的股份对应的表决权、召集权、提名和提案权、参会权等相关权利委托给 苍南芯盛行使（以下简称"本次表决权委托"）。本次表决权委托的期限为 36 个月，自公司股东会审议通过本次表决权委托相关事项之日起生效。 证券代码：300078 证券简称：思创医惠 公告编号：2025-112 思创医惠科技股份有限公司 关于重新签署《股份转让协议》《表决权委托协议》构成管理层收购 暨公司控制权拟发生变更和权益变动的提示性公告 公司股东路楠先生及其一致行动人杭州博泰投资管理有限公司、受让方苍南 芯盛企业管理合伙企业（有限合伙）及其一致行动人苍南芯创企业管理合伙企业 （有限合伙）、苍南县思加物联智能合伙企业（有限合伙）保证向本公司提供的 信息内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息 ...